Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded
- Contract number
- SPE2DB25FQQZA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,322
Award facts
- Contract value 100% obligated
- $14,322.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,322.26 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on May 27, 2025. This competitively awarded, firm fixed-price delivery order is structured with an ultimate completion date of May 28, 2025, and carries no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone analog used in the treatment of osteoporosis, representing a specialized pharmaceutical product critical to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this prime IDC to deliver a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems globally. The company's substantial contract history with DLA demonstrates its capability to manage high-volume federal pharmaceutical procurement across multiple therapeutic domains while maintaining competitive pricing and reliable supply chain management.
Quick answers
Who was awarded contract SPE2DB25FQQZA?
SPE2DB25FQQZA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FQQZA worth?
The government has obligated $14,322 on SPE2DB25FQQZA.
Is contract SPE2DB25FQQZA an order under another contract?
Yes. SPE2DB25FQQZA is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQQZA competed?
The extent of competition for SPE2DB25FQQZA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award